BillionToOne, Inc. (BLLN)
Last updated: 2026-11-19 03:40:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
BillionToOne, Inc. (BLLN) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $91.43, with a market capitalization of $4.60B and a P/E ratio of 101.38. Over the past 52 weeks, its price has ranged from $61.96 to $150.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$4.60B | |
$93.87 | |
$98.97 | |
$85.99 | |
$97.50 | |
1.37M | |
619.38K | |
101.38 | |
$150.44 | |
$61.96 | |
-- | |
2026-09-30 |
BillionToOne, Inc. (BLLN) Latest Closing Stock Price
BillionToOne, Inc. (BLLN) last closed at $91.43 as of 2026-11-19 00:40:00, down 6.19% ($6.04) from the previous close of $97.50.
During the latest regular trading session, BLLN traded between $85.99 and $98.97, with a volume of 1.37M shares. The closing price was near the middle and near the middle of its 52-week range.
Why Is BLLN Stock Up Today?
BLLN is up 0.25% as of the last close.
BillionToOne shares are trading lower after Fuzzy Panda Research issued a report on the company.
BillionToOne, Inc. (BLLN) 7-Day Stock Price Change
Over the past seven days, BillionToOne, Inc. (BLLN) moved from $114.95 to $91.43, representing a decline of 20.46% ($23.52).
The stock traded between $85.99 and $117.97 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 776.57 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BLLN 52-Week Price Position
Position in Range: 33.3%
BLLN is currently trading at $91.43, placing it 33.3% of the way from its 52-week low of $61.96 to its 52-week high of $150.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BillionToOne, Inc. (BLLN)?
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
BillionToOne, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 713 |
| Exchange | NASDAQ |
| Company Website |
BLLN News
Latest news related to BillionToOne, Inc. and BLLN stock.
- Read Full Article
- Read Full Article
BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
- Read Full Article
Fuzzy Panda Research Issues Report On BillionToOne; Claims Short Position
https://x.com/FuzzyPandaShort/status/2123052767518638093
- Read Full Article
TPG GP A Sells $485M Of LifeStance Health Stock Near 52-Week High
TPG GP A LLC, a 10% owner of LifeStance Health Group, Inc. (NASDAQ:LFST), sold 37,233,110 shares for $484.8 million on Nov. 12. The entity reduced its holdings by 46.72%, leaving 42,458,592 shares.LifeStance shares had
- Read Full Article
BillionToOne: 3 Key Takeaways for Long-Term Investors
BillionToOne raised 2026 revenue guidance to $460-470 million with Q3 revenue up 47% year-over-year to $123 million. The company achieved its fifth consecutive quarter of GAAP profitability while maintaining 71% gross margins. Key developments include the December 15 launch of Northstar Clear, a tissue-free blood test for cancer detection, and demonstrated superior performance of its Northstar Response test compared to tissue-dependent competitors.
Ways to Trade BLLN at MEXC
How to Buy BillionToOne, Inc. (BLLN) Stock on MEXC
Eligible investors can buy real shares of BillionToOne, Inc. (BLLN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BillionToOne, Inc. (BLLN) stock price today?
2.Is BLLN stock going up or down today?
3.What is BLLN pre-market price?
4.What is BLLN after-hours price?
5.Is BLLN stock trading now?
6.Where does BLLN sit relative to its 52-week high and low?
7.What sector is BillionToOne, Inc. in?
8.What is BillionToOne, Inc.'s market capitalization and where is it listed?
9.How is BLLN valued in terms of P/E ratio and EPS?
10.Does BillionToOne, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BLLN, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
BLLN Stock Calculator
Estimate the value between BLLN shares and USD.
BLLN Shares to USD
1.00 BLLN shares = 91.434 USD
Calculations are estimates based on the latest available price and are for reference only.


